← All sarcoma trials
Recruiting now—All ages

An Observational Study of Local Relapse After High Grade Osteosarcoma

Sponsor: Istituto Ortopedico Rizzoli · NCT06017518 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Osteosarcoma

Where it's running2 sites

2 international sites

  • IRCCS Istituto Ortopedico Rizzoli

    Bologna, BO, Italy 40136

    Recruiting now

  • Azienda Ospedaliero-Universitaria Pisana

    Pisa, PI, Italy 56126

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Patients who experienced LR as first event of recurrence after treatment for localized high-grade osteosarcoma of bone, including cases with synchronous lung metastases
* Adequate patient compliance to follow-up visits
* Written informed consent prior to any study-specific analysis and/or data collection
* No age limits

Exclusion Criteria:

* Cases of LR demonstrated after \> 3 months after metastatic disease
* Impossibility to ensure adequate compliance

Updated 2025-09-22 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.